255.59
USD
0.87
(0.34%)
Pre Open
Fair value202.30Plus+26%77Price 255.59264
Q4 FY2026 · Earnings report
EPS estimate 2.68Revenue estimate 3.04B
Q4 FY2026 · Earnings report
EPS estimate 2.68Revenue estimate 3.04B
Quest Diagnostics debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Quest Diagnostics's debt to equity ratio is 0.82: total debt of 6.29B USD against shareholders' equity of 7.63B USD.
- Today
- 0.82
- Average, 5 years
- 0.84
- Low, 5 years
- 0.72
- High, 5 years
- 1.02
Debt to equity = total debt ÷ shareholders' equity = 6.29B ÷ 7.63B = 0.82
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.82 | 6.29B | 7.63B | |
| FY2025 | 31 Dec 2025 | 0.96 | 6.92B | 7.17B |
| FY2024 | 31 Dec 2024 | 1.05 | 7.09B | 6.78B |
| FY2023 | 31 Dec 2023 | 0.87 | 5.50B | 6.31B |
| FY2022 | 31 Dec 2022 | 0.80 | 4.71B | 5.89B |
| FY2021 | 31 Dec 2021 | 0.74 | 4.77B | 6.44B |
| FY2020 | 31 Dec 2020 | 0.71 | 4.81B | 6.76B |
| FY2019 | 31 Dec 2019 | 0.96 | 5.42B | 5.64B |
| FY2018 | 31 Dec 2018 | 0.77 | 3.99B | 5.22B |
| FY2017 | 31 Dec 2017 | 0.78 | 3.86B | 4.92B |
| FY2016 | 31 Dec 2016 | 0.81 | 3.73B | 4.63B |
| FY2015 | 31 Dec 2015 | 0.78 | 3.65B | 4.68B |
| FY2014 | 31 Dec 2014 | 0.87 | 3.76B | 4.30B |
| FY2013 | 31 Dec 2013 | 0.84 | 3.33B | 3.95B |
| FY2012 | 31 Dec 2012 | 0.81 | 3.36B | 4.16B |
| FY2011 | 31 Dec 2011 | 1.09 | 4.02B | 3.69B |
| FY2010 | 31 Dec 2010 | 0.74 | 2.99B | 4.03B |
| FY2009 | 31 Dec 2009 | 0.78 | 3.11B | 3.99B |
| FY2008 | 31 Dec 2008 | 0.86 | 3.08B | 3.60B |
| FY2007 | 31 Dec 2007 | 1.07 | 3.54B | 3.32B |
| FY2006 | 31 Dec 2006 | 0.52 | 1.56B | 3.02B |
| FY2005 | 31 Dec 2005 | 0.58 | 1.59B | 2.76B |
| FY2004 | 31 Dec 2004 | 0.48 | 1.10B | 2.29B |
| FY2003 | 31 Dec 2003 | 0.46 | 1.10B | 2.39B |
| FY2002 | 31 Dec 2002 | 0.47 | 822.54M | 1.77B |
| FY2001 | 31 Dec 2001 | 0.62 | 821.74M | 1.34B |
| FY2000 | 31 Dec 2000 | 0.99 | 1.03B | 1.03B |
| FY1999 | 31 Dec 1999 | 1.41 | 1.22B | 863.10M |
| FY1998 | 31 Dec 1998 | 0.82 | 464.80M | 567.90M |
| FY1997 | 31 Dec 1997 | 0.95 | 514.80M | 541.70M |
| FY1996 | 31 Dec 1996 | 0.99 | 535.79M | 538.72M |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.82 | 6.29B | 7.63B |
| Q2 FY2026 | 30 Jun 2026 | 0.85 | 6.38B | 7.52B |
| Q1 FY2026 | 31 Mar 2026 | 0.95 | 6.98B | 7.37B |
| Q4 FY2025 | 31 Dec 2025 | 0.96 | 6.92B | 7.17B |
| Q3 FY2025 | 30 Sept 2025 | 0.88 | 6.38B | 7.26B |
| Q2 FY2025 | 30 Jun 2025 | 0.88 | 6.38B | 7.23B |
| Q1 FY2025 | 31 Mar 2025 | 0.95 | 6.57B | 6.93B |
| Q4 FY2024 | 31 Dec 2024 | 1.02 | 6.93B | 6.78B |
| Q3 FY2024 | 30 Sept 2024 | 1.02 | 6.97B | 6.81B |
| Q2 FY2024 | 30 Jun 2024 | 0.77 | 5.09B | 6.62B |
| Q1 FY2024 | 31 Mar 2024 | 0.83 | 5.35B | 6.43B |
| Q4 FY2023 | 31 Dec 2023 | 0.85 | 5.37B | 6.31B |
| Q3 FY2023 | 30 Sept 2023 | 0.76 | 4.91B | 6.43B |
| Q2 FY2023 | 30 Jun 2023 | 0.79 | 4.96B | 6.25B |
| Q1 FY2023 | 31 Mar 2023 | 0.76 | 4.62B | 6.05B |
| Q4 FY2022 | 31 Dec 2022 | 0.78 | 4.62B | 5.89B |
| Q3 FY2022 | 30 Sept 2022 | 0.74 | 4.64B | 6.24B |
| Q2 FY2022 | 30 Jun 2022 | 0.72 | 4.64B | 6.41B |
| Q1 FY2022 | 31 Mar 2022 | 0.73 | 4.66B | 6.38B |
| Q4 FY2021 | 31 Dec 2021 | 0.72 | 4.66B | 6.44B |
| Q3 FY2021 | 30 Sept 2021 | 0.73 | 4.65B | 6.39B |
| Q2 FY2021 | 30 Jun 2021 | 0.79 | 4.65B | 5.90B |
| Q1 FY2021 | 31 Mar 2021 | 0.69 | 4.66B | 6.75B |
| Q4 FY2020 | 31 Dec 2020 | 0.69 | 4.66B | 6.76B |
| Q3 FY2020 | 30 Sept 2020 | 0.80 | 5.15B | 6.40B |
| Q2 FY2020 | 30 Jun 2020 | 0.88 | 5.14B | 5.83B |
| Q1 FY2020 | 31 Mar 2020 | 0.81 | 4.59B | 5.66B |
| Q4 FY2019 | 31 Dec 2019 | 0.94 | 5.33B | 5.64B |
| Q3 FY2019 | 30 Sept 2019 | 0.81 | 4.55B | 5.61B |
| Q2 FY2019 | 30 Jun 2019 | 0.83 | 4.54B | 5.46B |
| Q1 FY2019 | 31 Mar 2019 | 0.90 | 4.78B | 5.29B |
| Q4 FY2018 | 31 Dec 2018 | 0.75 | 3.89B | 5.22B |
| Q3 FY2018 | 30 Sept 2018 | 0.70 | 3.70B | 5.32B |
| Q2 FY2018 | 30 Jun 2018 | 0.71 | 3.71B | 5.22B |
| Q1 FY2018 | 31 Mar 2018 | 0.77 | 3.86B | 5.03B |
| Q4 FY2017 | 31 Dec 2017 | 0.77 | 3.78B | 4.92B |
| Q3 FY2017 | 30 Sept 2017 | 0.79 | 3.76B | 4.79B |
| Q2 FY2017 | 30 Jun 2017 | 0.80 | 3.74B | 4.70B |
| Q1 FY2017 | 31 Mar 2017 | 0.81 | 3.73B | 4.63B |
| Q4 FY2016 | 31 Dec 2016 | 0.81 | 3.73B | 4.63B |
| Q3 FY2016 | 30 Sept 2016 | 0.82 | 3.82B | 4.66B |
| Q2 FY2016 | 30 Jun 2016 | 0.85 | 3.84B | 4.54B |
| Q1 FY2016 | 31 Mar 2016 | 0.84 | 3.90B | 4.64B |
| Q4 FY2015 | 31 Dec 2015 | 0.78 | 3.65B | 4.68B |
| Q3 FY2015 | 30 Sept 2015 | 0.81 | 3.73B | 4.59B |
| Q2 FY2015 | 30 Jun 2015 | 0.87 | 3.74B | 4.31B |
| Q1 FY2015 | 31 Mar 2015 | 1.12 | 4.73B | 4.24B |
| Q4 FY2014 | 31 Dec 2014 | 0.87 | 3.74B | 4.30B |
| Q3 FY2014 | 30 Sept 2014 | 0.92 | 3.86B | 4.18B |
| Q2 FY2014 | 30 Jun 2014 | 0.97 | 3.96B | 4.09B |
| Q1 FY2014 | 31 Mar 2014 | 0.99 | 3.95B | 3.99B |
| Q4 FY2013 | 31 Dec 2013 | 0.84 | 3.33B | 3.95B |
| Q3 FY2013 | 30 Sept 2013 | 0.88 | 3.37B | 3.84B |
| Q2 FY2013 | 30 Jun 2013 | 0.89 | 3.50B | 3.91B |
| Q1 FY2013 | 31 Mar 2013 | 0.81 | 3.40B | 4.20B |
| Q4 FY2012 | 31 Dec 2012 | 0.81 | 3.36B | 4.16B |
| Q3 FY2012 | 30 Sept 2012 | 0.85 | 3.53B | 4.17B |
| Q2 FY2012 | 30 Jun 2012 | 0.96 | 3.82B | 4.00B |
| Q1 FY2012 | 31 Mar 2012 | 1.01 | 3.92B | 3.87B |
| Q4 FY2011 | 31 Dec 2011 | 1.09 | 4.02B | 3.69B |
| Q3 FY2011 | 30 Sept 2011 | 1.19 | 4.20B | 3.52B |
| Q2 FY2011 | 30 Jun 2011 | 1.26 | 4.33B | 3.43B |
| Q1 FY2011 | 31 Mar 2011 | 1.24 | 4.22B | 3.41B |
| Q4 FY2010 | 31 Dec 2010 | 0.74 | 2.99B | 4.03B |
| Q3 FY2010 | 30 Sept 2010 | 0.82 | 3.17B | 3.86B |
| Q2 FY2010 | 30 Jun 2010 | 0.80 | 3.14B | 3.92B |
| Q1 FY2010 | 31 Mar 2010 | 0.80 | 3.12B | 3.90B |
| Q4 FY2009 | 31 Dec 2009 | 0.78 | 3.11B | 3.99B |
| Q3 FY2009 | 30 Sept 2009 | 0.76 | 2.98B | 3.91B |
| Q2 FY2009 | 30 Jun 2009 | 0.82 | 3.08B | 3.74B |
| Q1 FY2009 | 31 Mar 2009 | 0.87 | 3.08B | 3.53B |
| Q4 FY2008 | 31 Dec 2008 | 0.86 | 3.08B | 3.60B |
| Q3 FY2008 | 30 Sept 2008 | 0.84 | 3.13B | 3.73B |
| Q2 FY2008 | 30 Jun 2008 | 0.89 | 3.26B | 3.67B |
| Q1 FY2008 | 31 Mar 2008 | 0.98 | 3.43B | 3.50B |
| Q4 FY2007 | 31 Dec 2007 | 1.07 | 3.54B | 3.32B |
| Q3 FY2007 | 30 Sept 2007 | 1.13 | 3.76B | 3.33B |
| Q2 FY2007 | 30 Jun 2007 | 1.23 | 3.91B | 3.19B |
| Q1 FY2007 | 31 Mar 2007 | 0.66 | 2.01B | 3.03B |
| Q4 FY2006 | 31 Dec 2006 | 0.52 | 1.56B | 3.02B |
| Q3 FY2006 | 30 Sept 2006 | 0.51 | 1.56B | 3.07B |
| Q2 FY2006 | 30 Jun 2006 | 0.53 | 1.53B | 2.90B |
| Q1 FY2006 | 31 Mar 2006 | 0.53 | 1.53B | 2.87B |
| Q4 FY2005 | 31 Dec 2005 | 0.58 | 1.59B | 2.76B |
| Q3 FY2005 | 30 Sept 2005 | 0.30 | 854.30M | 2.83B |
| Q2 FY2005 | 30 Jun 2005 | 0.31 | 854.24M | 2.78B |
| Q1 FY2005 | 31 Mar 2005 | 0.32 | 854.19M | 2.64B |
| Q4 FY2004 | 31 Dec 2004 | 0.48 | 1.10B | 2.29B |
| Q3 FY2004 | 30 Sept 2004 | 0.44 | 1.10B | 2.48B |
| Q2 FY2004 | 30 Jun 2004 | 0.45 | 1.10B | 2.44B |
| Q1 FY2004 | 31 Mar 2004 | 0.44 | 1.10B | 2.50B |
| Q4 FY2003 | 31 Dec 2003 | 0.46 | 1.10B | 2.39B |
| Q3 FY2003 | 30 Sept 2003 | 0.47 | 1.12B | 2.38B |
| Q2 FY2003 | 30 Jun 2003 | 0.48 | 1.14B | 2.37B |
| Q1 FY2003 | 31 Mar 2003 | 0.55 | 1.22B | 2.24B |
| Q4 FY2002 | 31 Dec 2002 | 0.47 | 822.54M | 1.77B |
| Q3 FY2002 | 30 Sept 2002 | 0.62 | 1.05B | 1.68B |
| Q2 FY2002 | 30 Jun 2002 | 0.72 | 1.12B | 1.57B |
| Q1 FY2002 | 31 Mar 2002 | 0.57 | 821.60M | 1.45B |
| Q4 FY2001 | 31 Dec 2001 | 0.62 | 821.74M | 1.34B |
| Q3 FY2001 | 30 Sept 2001 | 0.77 | 958.53M | 1.24B |
| Q2 FY2001 | 30 Jun 2001 | 0.87 | 1.01B | 1.16B |
| Q1 FY2001 | 31 Mar 2001 | 0.93 | 1.02B | 1.10B |
| Q4 FY2000 | 31 Dec 2000 | 0.99 | 1.03B | 1.03B |
| Q3 FY2000 | 30 Sept 2000 | 1.20 | 1.19B | 986.64M |
| Q2 FY2000 | 30 Jun 2000 | 1.27 | 1.19B | 941.32M |
| Q1 FY2000 | 31 Mar 2000 | 1.34 | 1.21B | 897.03M |
| Q4 FY1999 | 31 Dec 1999 | 1.41 | 1.22B | 863.10M |
| Q3 FY1999 | 30 Sept 1999 | 1.48 | 1.27B | 856.00M |
| Q2 FY1999 | 30 Jun 1999 | 0.67 | 399.90M | 597.80M |
| Q1 FY1999 | 31 Mar 1999 | 0.72 | 416.60M | 577.30M |
| Q4 FY1998 | 31 Dec 1998 | 0.82 | 464.80M | 567.90M |
| Q3 FY1998 | 30 Sept 1998 | 0.84 | 470.60M | 561.40M |
| Q2 FY1998 | 30 Jun 1998 | 0.87 | 489.00M | 560.60M |
| Q1 FY1998 | 31 Mar 1998 | 0.92 | 507.10M | 551.50M |
| Q4 FY1997 | 31 Dec 1997 | 0.95 | 514.80M | 541.70M |
| Q3 FY1997 | 30 Sept 1997 | 0.91 | 515.40M | 566.60M |
| Q2 FY1997 | 30 Jun 1997 | 0.92 | 515.70M | 561.20M |
| Q1 FY1997 | 31 Mar 1997 | 0.94 | 515.70M | 546.40M |
| Q4 FY1996 | 31 Dec 1996 | 0.99 | 536.00M | 539.00M |
| Q3 FY1996 | 30 Sept 1996 | 9.26 | 1.23B | 133.00M |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Current ratio,All ratios
Common questions about Quest Diagnostics's debt to equity
Source: Financial Modeling Prep
